Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology's Unit Gets Approval For Commercialisation Of Eye Drops In China

July 17 (Reuters) - Essex Bio-Technology Ltd  1061.HK :
    * UNIT GETS APPROVAL FROM STATE DRUG ADMINISTRATION FOR
COMMERCIALISATION OF SINGLE-DOSE LEVOFLOXACIN EYE DROPS IN CHINA

Source text for Eikon:  ID:nHKS3jLDp8 
Further company coverage:  1061.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news